Marked loss of adipose tissue during neoadjuvant therapy as a predictor for poor prognosis in patients with gastric cancer: A retrospective cohort study

被引:18
作者
Zhang, Yingjing [1 ]
Li, Zijian [1 ]
Jiang, Lin [1 ]
Xue, Zhigang [1 ]
Ma, Zhiqiang [1 ]
Kang, Weiming [1 ]
Ye, Xin [1 ]
Liu, Yuqin [2 ]
Jin, Zhengyu [3 ]
Yu, Jianchun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Basic Med Sci, Cell Culture Ctr, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China
关键词
gastric cancer; neoadjuvant therapy; body composition changes; prognosis; BODY-MASS INDEX; SKELETAL-MUSCLE; COMPUTED-TOMOGRAPHY; PERIOPERATIVE CHEMOTHERAPY; VISCERAL FAT; SURVIVAL; SARCOPENIA; COMPLICATIONS; CIRCUMFERENCE; SURGERY;
D O I
10.1111/jhn.12861
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background The influence of body composition changes during neoadjuvant treatment (NT) on long-term survival in patients with gastric cancer (GC) undergoing radical gastrectomy remains unclear. The present study aimed to explore the association between changes in body composition during NT and survival in patients with GC. Methods GC patients treated with NT and radical gastrectomy between 2015 and 2018 were included in this retrospective study. Skeletal muscle mass, visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were measured by computer tomography before and after NT. Body composition changes during NT were compared with Kaplan-Meier curves. Univariate and multivariate regression analyses were applied to determine the predictors of overall survival (OS) and disease-free survival (DFS). Results In total, 157 GC patients were studied. A marked loss of adipose tissue was associated with poor nutritional status. The median follow-up time for all patients was 25 months. Patients with marked VAT loss (>= 35.7%) during NT had significantly shorter OS (p = 0.028) and DFS (p = 0.03). Similarly, poorer OS (p = 0.033) and DFS (p = 0.003) were observed in patients with marked SAT loss (>= 30.1%) during NT. Changes in skeletal muscle mass and body weight during NT were not associated with survival. Marked VAT loss accompanied by marked SAT loss was an independent predictor of OS (hazards ratio = 2.447; p = 0.045) and DFS (hazards ratio = 2.674; p = 0.018). Conclusions Patients with locally advanced GC have a worse survival when they experienced marked loss of adipose tissue during NT.
引用
收藏
页码:585 / 594
页数:10
相关论文
共 49 条
[1]   Adipose tissue volume is decreased in recently diagnosed cancer patients with cachexia [J].
Agustsson, Thorhallur ;
Wikrantz, Pal ;
Ryden, Mikael ;
Brismar, Torkel ;
Isaksson, Bengt .
NUTRITION, 2012, 28 (09) :851-855
[2]   Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].
Allemani, Claudia ;
Matsuda, Tomohiro ;
Di Carlo, Veronica ;
Harewood, Rhea ;
Matz, Melissa ;
Niksic, Maja ;
Bonaventure, Audrey ;
Valkov, Mikhail ;
Johnson, Christopher J. ;
Esteve, Jacques ;
Ogunbiyi, Olufemi J. ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Eser, Sultan ;
Engholm, Gerda ;
Stiller, Charles A. ;
Monnereau, Alain ;
Woods, Ryan R. ;
Visser, Otto ;
Lim, Gek Hsiang ;
Aitken, Joanne ;
Weir, Hannah K. ;
Coleman, Michel P. .
LANCET, 2018, 391 (10125) :1023-1075
[3]  
Amin MB, 2017, AJCC cancer staging manual, Veighth
[4]   ESPEN expert group recommendations for action against cancer-related malnutrition [J].
Arends, J. ;
Baracos, V. ;
Bertz, H. ;
Bozzetti, F. ;
Calder, P. C. ;
Deutz, N. E. P. ;
Erickson, N. ;
Laviano, A. ;
Lisanti, M. P. ;
Lobo, D. N. ;
McMillan, D. C. ;
Muscaritoli, M. ;
Ockenga, J. ;
Pirlich, M. ;
Strasser, F. ;
de van der Schueren, M. ;
Van Gossum, A. ;
Vaupel, P. ;
Weimann, A. .
CLINICAL NUTRITION, 2017, 36 (05) :1187-1196
[5]   Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer [J].
Awad, Sherif ;
Tan, Benjamin H. ;
Cui, Helen ;
Bhalla, Ashish ;
Fearon, Kenneth C. H. ;
Parsons, Simon L. ;
Caton, James A. ;
Lobo, Dileep N. .
CLINICAL NUTRITION, 2012, 31 (01) :74-77
[6]   Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer [J].
Blauwhoff-Buskermolen, Susanne ;
Versteeg, Kathelijn S. ;
de van der Schueren, Marian A. E. ;
den Braver, Nicole R. ;
Berkhof, Johannes ;
Langius, Jacqueline A. E. ;
Verheul, Henk M. W. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (12) :1339-+
[7]  
CAMP RL, 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]
[8]   Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer [J].
Choi, Moon Hyung ;
Oh, Soon Nam ;
Lee, In Kyu ;
Oh, Seong Taek ;
Won, Daeyoun David .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2018, 9 (01) :53-59
[9]   Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer [J].
Cooper, Amanda B. ;
Slack, Rebecca ;
Fogelman, David ;
Holmes, Holly M. ;
Petzel, Maria ;
Parker, Nathan ;
Balachandran, Aparna ;
Garg, Naveen ;
Ngo-Huang, An ;
Varadhachary, Gauri ;
Evans, Douglas B. ;
Lee, Jeffrey E. ;
Aloia, Thomas ;
Conrad, Claudius ;
Vauthey, Jean-Nicolas ;
Fleming, Jason B. ;
Katz, Matthew H. G. .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (07) :2416-2423
[10]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20